PATENT CLAIM ANALYSIS

Application Number: 16111158
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["424", "174100"]

Abstract:
The present invention relates to compositions and methods for immunotherapy of a subject afflicted with diseases such as cancer, an infectious disease, or a neurodegenerative disease, which methods comprise administering to the subject a composition comprising a therapeutically effective amount of an anti-PD-L1 antibody or portion thereof that potentiates an endogenous immune response, either stimulating the activation of the endogenous response or inhibiting the suppression of the endogenous response.

Claim (Index 16):
A pharmaceutical composition comprising an antibody according to  claim 1 .

Metadata:
- Claim Count in Document: 16.0
- Percentile: 96.0
- Lexical Diversity: 1.5102
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15620771', '15328232', '15328225', '15744737', '16100019']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7609132993645372
- 35 USC 102 Novelty (BERT): 0.5921032112154686
- Combined Prediction Score: 0.7440322905496304
- Mean Citation Score: 479.97426400000006
- Max Citation Score: 535.1266
- Similarity Product: 421.6815403433562

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test